Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Implantation: A Bayesian Meta-analysis of Randomized Controlled Trials
Canadian Journal of Cardiology · 2026-07
DOI: 10.1016/j.cjca.2026.06.024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Cardiology, 2026-07. Verfasst von Pedro Gomes Batista und 6 weiteren Autor:innen. Beteiligte Einrichtung: Federal University of Paraíba, João Pessoa, Paraíba, Brazil. Electronic address: pedro.batista@academico.ufpb.br. Die Arbeit nennt 47 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND The optimal management of concomitant coronary artery disease (CAD) during transcatheter aortic valve implantation (TAVI) remains controversial due to conflicting data from randomized controlled trials (RCTs). METHODS A systematic review and Bayesian meta-analysis of RCTs (through April 2026) compared pre-TAVI percutaneous coronary intervention (PCI) versus conservative management in TAVI patients with CAD. Effect measures were risk ratios (RRs) with 95% credible intervals (CrIs) using a Bayesian random-effects model. RESULTS Three RCTs involving 1,156 patients were included, with 579 (50%) randomized to pre-TAVI PCI. No evidence of benefit was observed for myocardial infarction (RR, 0.83; 95% CrI, 0.44 to 1.60), all-cause mortality (RR, 0.92; 95% CrI, 0.62 to 1.35), acute kidney injury (RR, 1.01; 95% CrI, 0.41 to 2.73), rehospitalization (RR, 1.08; 95% CrI, 0.67 to 1.75), cardiovascular death (RR, 0.74; 95% CrI, 0.44 to 1.24) or stroke (RR, 0.71; 95% CrI, 0.42 to 1.20). Although pre-TAVI PCI was associated with fewer subsequent revascularizations (RR, 0.27; 95% CrI, 0.11 to 0.66), this outcome is vulnerable to ascertainment and treatment bias. Conversely, point estimates favored conservative management for major bleeding (RR, 1.57; 95% CrI, 0.96 to 2.57). CONCLUSION Pre-TAVI PCI yielded no hard clinical benefits and likely increased major bleeding risk. While it reduced subsequent revascularizations, a soft, clinician-driven endpoint, this did not improve hospital-free survival. These findings strongly support a selective, lesion-guided approach over routine intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Federal University of Paraíba, João Pessoa, Paraíba, Brazil. Electronic address: pedro.batista@academico.ufpb.br.
- Federal University of Ceará, Fortaleza, Ceará, Brazil.
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Pontifical Catholic University of Paraná, Curitiba, Paraná, Brazil.
- University of Pernambuco, Recife, Pernambuco, Brazil.
- University Center for the Development of Alto Vale, Rio do Sul, Santa Catarina, Brazil.
Zitieren
APA
Batista, P. G., Albino Dos Santos Silva, R. R., Malik, M., Gaelzer, G. C., Montenegro, M. V., Fischer Bacca, C. O., & Giorgi, J. (2026). Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Implantation: A Bayesian Meta-analysis of Randomized Controlled Trials. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2026.06.024
Vancouver
Batista PG, Albino Dos Santos Silva RR, Malik M, Gaelzer GC, Montenegro MV, Fischer Bacca CO, et al. Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Implantation: A Bayesian Meta-analysis of Randomized Controlled Trials. Canadian Journal of Cardiology. 2026. doi:10.1016/j.cjca.2026.06.024
BibTeX
@article{Batista2026,
author = {Batista, Pedro Gomes and Albino Dos Santos Silva, Railla Raquel and Malik, Mushrin and Gaelzer, Giulia Caldeira and Montenegro, Marcela Vasconcelos and Fischer Bacca, Caroline O and Giorgi, Juliana},
title = {Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Implantation: A Bayesian Meta-analysis of Randomized Controlled Trials},
journal = {Canadian Journal of Cardiology},
year = {2026},
doi = {10.1016/j.cjca.2026.06.024}
}
EUVIMED